Home > Healthcare > Medical Devices > Surgical Devices > Thrombectomy Devices Market

Thrombectomy Devices Market Size

  • Report ID: GMI5245
  • Published Date: Sep 2023
  • Report Format: PDF

 Thrombectomy Devices Market Size

Thrombectomy Devices Market size was worth USD 1.4 billion in 2022 and is estimated to expand significantly at 7.3% CAGR from 2023 to 2032, driven by the increasing prevalence of cardiovascular disorders and the surging need for effective treatment procedures worldwide.

 

The increasing burden of sedentary lifestyles in both developed and developing countries is dramatically increasing the frequency of cardiovascular diseases, propelling the demand for thrombectomy operations. The rising instances of disease-related mortality is further driving the need for efficient treatment methods. For instance, the WHO estimates that cardiovascular disease causes more than 17 million deaths yearly, or around 31% of all fatalities worldwide. Patients with such long-term cardiac issues may have platelet aggregation or clotting, thus, raising the possibility of abrupt heart failure or heart attack, subsequently driving the industry landscape. 

 

The rising exposure to various regulations and guidelines established by regulating authorities may impede the thrombectomy devices market progress. While regulations are vital for patient safety and product quality, the presence of overly complex and stringent frameworks is leading to restrained innovation. The lengthy approval processes and rigorous compliance requirements is also making way for delays in product launches, increasing development costs, and limited market access for new entrants. However, the rising efforts towards streamlining the regulatory processes and promoting clearer communication along with the continued advancements in thrombectomy device technologies will assist in the market growth.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Thrombectomy devices industry size was worth USD 1.4 billion in 2022 and is projected to record 7.3% CAGR from 2023 to 2032, owing to the rising prevalence of cardiovascular disorders worldwide.

Mechanical/fragmentation segment generated more than USD 425 million in revenue in 2022 and is poised to witness substantial growth at 7.1% CAGR from 2023-2032 owing to increasing usage to offer improved efficacy in the treatment of diseases.

North America thrombectomy devices market size is expected to witness 7.4% CAGR from 2023-2032 attributed to the growing awareness regarding vascular diseases among the population, the increase in healthcare expenditure, favorable reimbursement scenarios, and government initiatives.

Some prominent firms in the thrombectomy devices industry are Lemaitre Vascular Inc., Boston Scientific Corporation, Medtronic Plc., Penumbra, Inc., Edwards Lifesciences Corporation, Teleflex Incorporated, Stryker Corporation, Johnson & Johnson Services Inc., and Terumo Corporation.

Thrombectomy Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 266
  • Countries covered: 30
  • Pages: 192
 Download Free Sample